Biodesix (BDSX) Depreciation & Amortization (CF) (2019 - 2026)

Biodesix (BDSX) has reported Depreciation & Amortization (CF) for 8 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $1.4 million, down 3.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (down 2.92% YoY), and the FY2025 annual result was $5.7 million, down 1.78% from the prior year.
• Depreciation & Amortization (CF) was $1.4 million for Q1 2026 at Biodesix, up from $1.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.5 million in Q3 2024 and troughed at $782000.0 in Q3 2023.
• Average Depreciation & Amortization (CF) over 5 years is $1.2 million, with a median of $1.4 million recorded in 2025.
• Year-over-year, Depreciation & Amortization (CF) slipped 13.55% in 2023 and jumped 90.92% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $898000.0 in 2022, then climbed by 8.8% to $977000.0 in 2023, then jumped by 48.31% to $1.4 million in 2024, then retreated by 4.28% to $1.4 million in 2025, then grew by 0.65% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.